The activation of the type I IFN pathway and increased expression of IFN-regulated genes are common to various SAID, including SLE [18, 19] and dermatomyositis (DM), a clinical phenotype of the IIM with characteristic skin rashes and other cutaneous findings [20, 21]. This evidence concerns the gene IFNA1 and dermatomyositis.